loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Prestwick3_000305

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Nortec Quimica Bupivacaine

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Prestwick3_000305

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 899Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pacira BioSciences Reports Inducement Grants Under Nasdaq
    Pacira BioSciences Reports Inducement Grants Under Nasdaq

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2943191/0/en/Pacira-BioSciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    ZYNRELEF Included As Qualifying Product Under Proposed Non-Opioid Policy
    ZYNRELEF Included As Qualifying Product Under Proposed Non-Opioid Policy

    15 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-announces-the-inclusion-of-zynrelef-as-a-qualifying-product-under-the-proposed-2025-non-opioid-policy-for-pain-relief-under-the-opps-and-the-asc-payment-system-302196793.html

    PR NEWSWIRE
    15 Jul 2024
    Share Share
    CMS Proposes New EXPAREL Reimbursement For Outpatient Surgery In 2025
    CMS Proposes New EXPAREL Reimbursement For Outpatient Surgery In 2025

    10 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/10/2911451/0/en/Centers-for-Medicare-and-Medicaid-Propose-New-Reimbursement-for-EXPAREL-in-All-Outpatient-Surgical-Environments-Beginning-January-1-2025.html

    GLOBENEWSWIRE
    10 Jul 2024
    Share Share
    Hengrui Pharma's Generic Bupivacaine liposome Receives Approval in US
    Hengrui Pharma's Generic Bupivacaine liposome Receives Approval in US

    02 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214348

    FDA
    02 Jul 2024
    Share Share
    Heron's ZYNRELEF Vial Access Needle Application Accepted
    Heron's ZYNRELEF Vial Access Needle Application Accepted

    02 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-announces-acceptance-of-the-prior-approval-supplement-application-for-zynrelef-vial-access-needle-van-302187706.html

    PR NEWSWIRE
    02 Jul 2024
    Share Share
    Heron Submits PAS For ZYNRELEF Vial Access Needle To FDA
    Heron Submits PAS For ZYNRELEF Vial Access Needle To FDA

    31 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-announces-prior-approval-supplement-submission-to-the-fda-for-zynrelef-vial-access-needle-van-302157344.html

    PR NEWSWIRE
    31 May 2024
    Share Share